{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:14:14Z","timestamp":1761491654563,"version":"3.37.3"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["4R33AG069794"],"award-info":[{"award-number":["4R33AG069794"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Context<\/jats:title>\n<jats:p>Potentially inappropriate prescribing of medications in older adults, particular those with dementia, can lead to adverse drug events including falls and fractures, worsening cognitive impairment, emergency department visits, and hospitalizations. Educational mailings from health plans to patients and their providers to encourage deprescribing conversations may represent an effective, low-cost, \u201clight touch\u201d, approach to reducing the burden of potentially inappropriate prescription use in older adults with dementia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>The objective of the <jats:bold>D<\/jats:bold>eveloping a <jats:bold>PR<\/jats:bold>ogram to <jats:bold>E<\/jats:bold>ducate and <jats:bold>S<\/jats:bold>ensitize <jats:bold>C<\/jats:bold>aregivers to <jats:bold>R<\/jats:bold>educe the <jats:bold>I<\/jats:bold>nappropriate Prescription <jats:bold>B<\/jats:bold>urden in <jats:bold>E<\/jats:bold>lderly with <jats:bold>A<\/jats:bold>lzheimer\u2019s <jats:bold>D<\/jats:bold>isease (D-PRESCRIBE-AD) trial is to evaluate the effect of a health plan based multi-faceted educational outreach intervention to community dwelling patients with dementia who are currently prescribed sedative\/hypnotics, antipsychotics, or strong anticholinergics.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The D-PRESCRIBE-AD is an open-label pragmatic, prospective randomized controlled trial (RCT) comparing three arms: 1) educational mailing to both the health plan patient and their prescribing physician (patient plus physician arm, n = 4814); 2) educational mailing to prescribing physician only (physician only arm, n = 4814); and 3) usual care (n = 4814) among patients with dementia enrolled in two large United States based health plans. The primary outcome is the absence of any dispensing of the targeted potentially inappropriate prescription during the 6-month study observation period after a 3-month black out period following the mailing. Secondary outcomes include dose-reduction, polypharmacy, healthcare utilization, mortality and therapeutic switching within targeted drug classes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This large pragmatic RCT will contribute to the evidence base on promoting deprescribing of potentially inappropriate medications among older adults with dementia. If successful, such light touch, inexpensive and highly scalable interventions have the potential to reduce the burden of potentially inappropriate prescribing for patients with dementia.<\/jats:p>\n<jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05147428\" xlink:type=\"simple\">NCT05147428<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0297562","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T18:24:06Z","timestamp":1707762246000},"page":"e0297562","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer\u2019s Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-941X","authenticated-orcid":true,"given":"Sonal","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle M.","family":"Cocoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary T.","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-4566","authenticated-orcid":true,"given":"Lauren","family":"Parlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Paullin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Harkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Dashevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Massino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Saphirak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybil L.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry H.","family":"Gurwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"pone.0297562.ref001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12877-022-02757-6","article-title":"Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing","volume":"22","author":"V Scharner","year":"2022","journal-title":"BMC Geriatr"},{"key":"pone.0297562.ref002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40801-021-00265-4","article-title":"Potentially Inappropriate Medication Use in Older Adults with Alzheimer\u2019s Disease and Related Dementias Living in the Community: A Cross-Sectional Analysis","volume":"8","author":"LE Vickers","year":"2021","journal-title":"Drugs Real World Outcomes"},{"key":"pone.0297562.ref003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-018-02612-x","article-title":"Identifying potentially inappropriate prescribing in older people with dementia: a systematic review","volume":"75","author":"D Hukins","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0297562.ref004","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ageing\/afaa147","article-title":"Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes","volume":"50","author":"J Delgado","year":"2021","journal-title":"Age Ageing"},{"key":"pone.0297562.ref005","doi-asserted-by":"crossref","first-page":"e029172","DOI":"10.1136\/bmjopen-2019-029172","article-title":"Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007","volume":"10","author":"J Delgado","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0297562.ref006","first-page":"1","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","author":"By the American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"JAGS"},{"key":"pone.0297562.ref007","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221118143","article-title":"Motivating deprescribing conversations for patients with Alzheimer\u2019s disease and related dementias: a descriptive study","volume":"13","author":"MT Antonelli","year":"2022","journal-title":"Ther Adv Drug Saf"},{"key":"pone.0297562.ref008","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamapsychiatry.2018.1867","article-title":"Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial","volume":"75","author":"A Sacarny","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"pone.0297562.ref009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1377\/hlthaff.2015.1025","article-title":"Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers","volume":"35","author":"A Sacarny","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"pone.0297562.ref010","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical TrialEffect of a Pharmacist-Led Intervention on Inappropriate Prescriptions in Older AdultsEffect of a Pharmacist-Led Intervention on Inappropriate Prescriptions in Older Adults","volume":"320","author":"P Martin","year":"2018","journal-title":"JAMA"},{"key":"pone.0297562.ref011","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2022.0502","article-title":"Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial","volume":"182","author":"EA Bayliss","year":"2022","journal-title":"JAMA Intern Med"},{"key":"pone.0297562.ref012","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMp1809643","article-title":"The FDA Sentinel Initiative\u2014An Evolving National Resource","volume":"379","author":"R Platt","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"pone.0297562.ref013","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"K Loudon","year":"2015","journal-title":"Bmj"},{"key":"pone.0297562.ref014","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"KE Thorpe","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"pone.0297562.ref015","article-title":"Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren\u2019t so simple","author":"NM Cocoros","year":"2023","journal-title":"Clin Trials"},{"issue":"Suppl 1","key":"pone.0297562.ref016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pds.2336","article-title":"Design considerations, architecture, and use of the Mini-Sentinel distributed data system","volume":"21","author":"LH Curtis","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0297562.ref017","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial","volume":"320","author":"P Martin","year":"2018","journal-title":"JAMA"},{"key":"pone.0297562.ref018","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"C Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"pone.0297562.ref019","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620968310","article-title":"Prescribing cascades in persons with Alzheimer\u2019s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials","volume":"11","author":"S Bloomstone","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"pone.0297562.ref020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1377\/hlthaff.2012.1061","article-title":"What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs","volume":"32","author":"JH Hibbard","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"pone.0297562.ref021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/JAD-170905","article-title":"Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study","volume":"63","author":"RU Kristensen","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"pone.0297562.ref022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"J Fine","year":"1999","journal-title":"Journal of the American Statistical Association"},{"key":"pone.0297562.ref023","volume-title":"The statistical analysis of failure time data","author":"J Kalbfleisch","year":"2011","edition":"2"},{"key":"pone.0297562.ref024","volume-title":"Nonparametric Statistical Methods","author":"M Hollander","year":"1999","edition":"2"},{"volume-title":"Statistical analysis with missing data","year":"2019","author":"RJ Little","key":"pone.0297562.ref025"},{"key":"pone.0297562.ref026","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ije\/dyu262","article-title":"Joint modelling of repeated measurement and time-to-event data: an introductory tutorial","volume":"44","author":"\u00d6 Asar","year":"2015","journal-title":"Int J Epidemiol"},{"key":"pone.0297562.ref027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/1047-2797(93)90012-S","article-title":"Level of education and change in cognitive function in a community population of older persons","volume":"3","author":"DA Evans","year":"1993","journal-title":"Ann Epidemiol"},{"key":"pone.0297562.ref028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00952990.2011.597280","article-title":"Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial","volume":"37","author":"MC Hu","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"pone.0297562.ref029","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pds.5230","article-title":"Identifying prescribing cascades in Alzheimer\u2019s disease and related dementias: The calcium channel blocker-diuretic prescribing cascade","volume":"30","author":"S Singh","year":"2021","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"pone.0297562.ref030","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/jgs.17013","article-title":"Antidopaminergic-Antiparkinsonian Medication Prescribing Cascade in Persons with Alzheimer\u2019s Disease","volume":"69","author":"S Singh","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"pone.0297562.ref031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1740774520928426","article-title":"Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial","volume":"17","author":"CJ Garcia","year":"2020","journal-title":"Clinical Trials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T18:24:24Z","timestamp":1707762264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297562"}},"subtitle":[],"editor":[{"given":"Johanna","family":"Pruller","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0297562","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,2,12]]}}}